SYNVANTAGE – US Trademark 90100048 of Syngene International Limited

Trademark image

SYNVANTAGE (U.S. Trademark Serial Number 90100048) is a United States trademark of Syngene International Limited. The goods and services include: Autonomic drugs for medical purposes for treatment of diseases and conditions in the fields of oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Diagnostic preparations for medical or veterinary purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for treating diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Dietary supplements for humans and animals; Biological tissue cultures for medical purposes; Biological preparations for the treatment of diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Pharmaceutical preparations for the treatment of infectious diseases; Bio-logical and biotechnological products pertaining to pharmaceutical and medical industries and formulations thereof for pharmaceutical and medical use, namely, pharmaceutical preparations for the treatment of diseases and conditions in the fields of oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; synthetic peptides for pharmaceutical purposes and for the treatment of diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; imaging agents for magnetic resonance imaging (MRI); nucleic acid sequences and chemical reagents for medical and veterinary purposes; pharmaceutical preparations and substances for the treatment of diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; biological tissue grafts; vascular grafts comprised of living tissue; biopharmaceuticals for the treatment of cancer; yeast and yeast extracts for medical, veterinary or pharmaceutical purposes; Protein arrays for medical diagnosis purposes; medicines for veterinary purposes for the treatment of skin allergies, ehrlichiosis, ear infection, diabetes, kennel cough, upper respiratory tract infection, coccidiosis, babesiosis, ectoparasites, endoparasites; isotopes for medical purposes; chemical preparations for medical purposes for use in DNA analysis; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Contrast media for in vivo imaging; Contrast agents for use in molecular imaging Chemicals for use in biotechnological manufacturing processes and product development; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Chemicals for use in industry and science; Biological preparations for use in industry and science; Enzymes derived from biotechnological processes for use in industry; enzyme substrates; enzyme stabilizers; Enzymes for scientific and research purposes; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory, research, clinical or medical laboratory use; chitosans for industrial purposes; aldehydes; chromatography chemicals; Stem cells for research purposes; cells for scientific, laboratory or medical research; Reagents for scientific and research use; nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; nucleotides for scientific and research use; Protein for industrial use; Proteins for use in manufacture; specialty chemicals, namely, chemical additives for general industrial use in the manufacture of a wide variety of goods; chemical reference standards for use in science and industry; isotopes for industrial purposes; biochemicals for in vitro and in vivo scientific use; Nucleic acid sequences, other than for medical or veterinary purposes; Reagents for scientific purposes for use in nucleic acid isolation and purification; gels, reagents, chemical standards, dyes and trace dyes for electrophoresis, other than for medical or veterinary purposes; preparative electrophoresis reagents, other than for medical or veterinary purposes Drug, alcohol and DNA screening for medical purposes; medical services; medical and pharmaceutical consultation; Medical diagnostic testing, monitoring and reporting services; pathology services for medical and diagnostic purposes. The correspondent is Mark A. Watkins of VORYS, SATRER, SEYMOUR AND PEASE LLP.

This trademark was filed on August 07, 2020 as United States Trademark Application Serial Number 90100048. This trademark application is still pending and does not yet have a registration number.

Trademark PTO Status History

July 04, 2022 – ABANDONMENT – NO USE STATEMENT FILED

June 22, 2022 – ASSIGNED TO PETITION STAFF

May 31, 2022 – TEAS PETITION TO AMEND BASIS RECEIVED

December 02, 2021 – NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

November 30, 2021 – SOU EXTENSION 1 GRANTED

November 30, 2021 – SOU EXTENSION 1 FILED

November 30, 2021 – TEAS EXTENSION RECEIVED

June 01, 2021 – NOA E-MAILED – SOU REQUIRED FROM APPLICANT

View full trademark status information at USPTO

Ownership History

Syngene International Limited

Syngene International Limited

View documents on file at USPTO

File a Trademark or Get Help With Trademark Law

Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.

Leave a Reply

Your email address will not be published. Required fields are marked *